On June 28, 2024, Rhia Ventures has filed an exempt solicitation statement and urged the shareholders to vote for its proposal request the Board issue a public report within one year of the annual meeting, omitting confidential information and at reasonable expense, detailing any known and potential risks or costs to the company caused by enacted or proposed state policies severely restricting reproductive rights or access to reproductive health medications, and detailing any strategies beyond litigation and legal compliance that the company may deploy to minimize or mitigate these risks.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
578.3 USD | +0.28% |
|
-1.91% | +24.90% |
07-15 | Morgan Stanley Adjusts Price Target on McKesson to $612 From $581, Maintains Overweight Rating | MT |
07-09 | AMN Healthcare Appoints Jim Hinton to Board of Directors Effective July 22 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.90% | 74.8B | |
-7.00% | 22.92B | |
+14.82% | 8.74B | |
-5.82% | 7.94B | |
-33.26% | 6.69B | |
+20.70% | 5.66B | |
-3.10% | 4.02B | |
+12.60% | 3.41B | |
+7.79% | 3.18B | |
-14.25% | 3.18B |
- Stock Market
- Equities
- MCK Stock
- News McKesson Corporation
- Rhia Ventures Files an Exempt Solicitation Statement and Request Vote for the Proposal